Lin et al. [32] studied the effect of mitramycin A in lung cancer cell lines and found that it decreases CpG island methylation, interacts with the catalytic pocket of DNMT1 inhibiting its activity, decreases DNMT1 protein levels and induces re-expression of silenced genes [32]. The gene discussed is DNMT1; the disease is lung carcinoma.